Unlocking the secrets of weight regain
New Scientist - 18-Nov-2024DNA changes in fat cells may explain rebound weight gain after treatment
Join the club for FREE to access the whole archive and other member benefits.
DNA changes in fat cells may explain rebound weight gain after treatment
Seven board members recently resigned after a failed buyout offer
Experts highlight the risks involved in trusting private companies with genetic data
Experts believe expanding this initiative could help save more lives
Experts highlight privacy risks for families and advocate stricter controls on DNA data use
Wearable sleep trackers may be causing more stress than rest
Findings highlight potential unintended effects of weight-loss medications on exercise motivation
Enhanced design and advanced algorithms promise improved accuracy and user experience
Modernized process for easy and personalized approach to take control of health
Biotech firm Bioage plans public debut as it advances promising obesity treatments
It offers a non-invasive alternative to blood lactate testing
A much better option than just prescribing drugs for life
Higher WWI correlates with shorter telomeres, suggesting increased health risks
While promising, concerns about data privacy have been raised
Blood sugar monitors might actually cause anxiety and unhealthy eating habits
Proved to be superior for weight loss, gut health, and metabolic improvements
Experts raise concerns about the effectiveness of its methods
Their test, MyPhenome, identifies different types of obesity to tailor treatment plans
Longevity AI app offers personalized guidance based on exercise, diet, and sleep data
Company aims to revolutionize preventative healthcare using health tracking system
Science behind blood sugar monitoring and its potential impact on healthy people
Study highlights the urgent need for healthy nutrition shift to address the alarming consequences
It reduced blood sugar spikes and overall levels in healthy individuals
Almost 4 million differences might be linked to disease risk, leading to targeted treatments
Significant systolic BP reductions, highlighting its potential to address health disparities